Why Recalls Skyrocket After Mergers and Acquisitions, and How to Avoid Them

During mergers and acquisitions (M&As), quality leaders face a unique and often underestimated risk window: processes haven't been harmonized yet, but the operational footprint has already expanded.

The dizzying scale and pace of these integrations make it difficult to tell what they add up to until failure points surface. Inconsistent CAPA rigor by site, multiple complaint intake paths, fragmented training records, and uneven document control all begin to crack under the pressure.

This is the reason why post-merger integration (PMI) needs more than just a 'system rollout.' It needs a single, connected quality backbone that standardizes execution while giving leadership a single source of truth.

The Hidden Cost Every MedTech Leader Underestimates

If you're a medical device manufacturer, a product recall is more than a regulatory headache; it's a patient safety risk, a reputational blow, and a costly operational disruption. Yet, despite stringent processes, recalls remain all too common across the industry.

According to data analyzed from FDA recall databases through Q1 2025, Class I recalls — the most serious category, carrying a reasonable probability of death or serious injury — rose a further 10.7%, even as overall recall volumes slightly declined. The recalls happening today are not just more frequent; they are getting more dangerous.

Organizations post-merger or acquisition are absorbing new plants, teams, and a new quality system. The challenge isn't a commitment to quality. It's a lack of visibility, harmonization, and standardization that comes with having two quality systems merges into one. In a post-merger environment, recall risk often surges due to one main reason: quality becomes fragmented before it becomes unified.

Different sites carry over different SOPs, complaint channels, CAPA rigor, training norms, supplier files, and tool ecosystems, so issues that were once contained can now spread across a broader footprint.

Scenario 1: The Case of the Faulty Heart Monitor (Design Control Gaps)

A fast-growing MedTech company launched an innovative wearable heart monitor, promising continuous cardiac tracking for at-risk patients. But soon after launching, users reported intermittent device failures.

Internally, the product team also integrated design inputs from a recently acquired R&D group. Requirements were living across different tools and formats. The root cause? Incomplete design verification and inadequate specification traceability.

Despite internal reviews, complex failure modes weren't captured early in the development process, leading to a global recall that damaged both patient trust and the company's brand.

Scenario 2: The Surgical Stapler Setback (Manufacturing Process Issues)

A leading surgical device manufacturer faced a recall when their automatic staplers started misfiring during procedures, causing tissue damage. Investigations revealed inconsistencies in the manufacturing process, specifically around equipment calibration and operator training.

The inconsistencies were compounded by a common post-acquisition dynamic: the consolidated sites were operating with divergent calibration practices, training norms, and local work protocols.

These deviations slipped through quality checks, exposing the gaps in process control and triggering a high-profile recall.

Scenario 3: The Regulatory Compliance Blind Spot (Documentation and Traceability Failures)

A startup producing orthopedic implants faced regulatory action when an audit uncovered missing batch records and incomplete supplier documentation.

Some of the missing or scattered documentation sat in legacy silos inherited through acquisition, and no one had a unified platform of record to prove integrity across the consolidated entity.

Though the implants themselves were functional, the lack of robust documentation and supplier quality controls violated regulatory requirements, forcing a preventive recall. The financial hit was significant, but the loss of market credibility was even worse.

The Pattern is Clear: Medical Device Recalls Happen Because of Gaps in the QMS

Whether due to design flaws, manufacturing process weaknesses, or documentation gaps, the root causes behind most medical device recalls can be traced to breakdowns in quality processes.

It is easy to be beguiled by compliance dashboards and audit scores. But with today's AI-powered Quality Management Systems (QMS), companies can move from reactive to proactive, spotting risks before they escalate.

In this blog, we will break down the top 3 causes of medical device recalls and explore how AI-driven quality management can help prevent them.

Recalls & the FDA: A Growing Focus on Transparency and Early Alerts

The FDA's medical device recall program has entered a new phase of transparency and proactive risk management.

The FDA's regulatory posture on medical device recalls shifted significantly in 2025. Following the success of its Early Alert pilot, CDRH expanded Early Alert Communications on September 29, 2025, now covering all medical devices for potentially high-risk removals or corrections, not just select categories.

A December 2025 GAO report found that around 4,000 medical devices were recalled between 2020 and 2024, underscoring the scale of the challenge driving this expansion. As per Sedgwick's 2025 Recall Index report, Class I withdrawals reached a 20-year high in Q2 2025 alone, with 36 safety actions impacting 4.29 million devices in a single quarter.

With serious product issues ranging from infusion pump failures to tracheostomy disconnections and surgical device defects making frequent headlines, manufacturers must double down on their internal quality and risk controls.

For organizations in the middle of integrating acquired sites and product lines, this imperative is even more acute, because regulators won't defer PMI timelines to align with audit readiness.

The FDA's evolving approach underscores an urgent industry reality. Preventing recalls starts with connected, AI-driven quality management, long before regulators step in.

The Top 3 Root Causes of Recalls and Can a Better QMS Reduce Recalls?

In M&A-heavy organizations, some of these root causes show up even more often, not because teams don't care! Rather, mainly because data, systems, and processes haven't been unified yet.

Design & Development Risks: Incomplete Design Controls and Traceability

Design flaws often stem from fragmented development processes, missing requirement traceability, or inadequate risk assessments.

How CQ Helps:

ComplianceQuest's integrated Design Control and Risk Management capabilities, part of the ProductQuest and QualityQuest suites, ensure that every user needs, design input, output, verification step, and validation activity are fully traceable.

Post-acquisition, this becomes paramount because design inputs, hazard analyses, and verification evidence are often split across teams and repositories, so traceability must work across the combined organization, not just within a single group.

• AI-powered Requirement Traceability Matrix (RTM) spots gaps automatically
• Risk management tools proactively surface potential hazards at the time of development
• Digital Design History File (DHF) / Design and Development File (DDF) provide real-time audit readiness
• CQ.AI helps teams identify relevant history faster (similar issues, prior decisions, linked records) so that inherited knowledge from acquired products doesn't get lost.
• CQ.AI "Trust Layer + Human-in-the-loop" makes sure that AI assistance remains governed for regulated workflows (audit trail, response validation concepts, oversight).

Process Deviations on the Shop Floor: Inconsistent Manufacturing and Operator Errors

Even the best product designs fail if the manufacturing process lacks control, consistency, and continuous monitoring.

How CQ Helps:

In post-merger environments, deviations skyrocket as sites don't share the same categorization habits, training rigor, or escalation thresholds yet, and frontline teams may avoid reporting in case the system feels unfamiliar.

• Conversational Issue / NC Reporting enables operators to report issues in simple language; CQ.AI structures the record automatically, increasing speed and consistency across newly integrated teams.
• Categorization Recommendations suggest likely defect/failure codes, minimizing guesswork and maximizing cross-site trend accuracy during harmonization.
• Similarity Search spots repeat patterns across NCs/CAPAs/complaints so that inherited issues don't reappear under a different label at another site.
• Investigation Assistant standardizes inputs (5W2H), recommends root causes and actions with citations, and generates narrative summaries for consistent investigation rigor.
• Embedded Analytics + Quality Maturity Index (QMI) provides leadership with a consistent performance view across sites, presenting where quality maturity is skyrocketing or dropping post-integration.
• Enhanced Next Best Actions (eNBAs) guide teams toward the next steps, decreasing turnaround time and missed accountability.

Documentation Gaps & Supplier Quality Failures: The Compliance Weak Link

Incomplete records, missing supplier documentation, or poor supplier controls can trigger regulatory recalls even if the product works as intended.

How CQ Helps:

After acquisitions, documentation gaps often stem from multiple document repositories, several templates, and inconsistent supplier qualification evidence. This makes it difficult to prove completeness during audits across the combined company.

ComplianceQuest's Supplier Management and Document Control solutions provide end-to-end visibility:

• Supplier Email Interaction converts supplier emails into structured interaction records (attachments captured, auto-classified, next steps triggered), directly feeding them into Centralized Document Management. Supplier documentation no longer dies in inboxes during PMI chaos.
• Document-based Knowledge Search helps teams spot the right controlled documents faster, effective when newly acquired sites are learning a new documentation system.
• AI-powered Summarization for investigations and records boosts consistency and audit readiness by generating clearer summaries from structured inputs. This is useful when teams carry different writing standards across newly integrated sites.

Proactive Quality Management and Risk Mitigation Hold the Key to Patient Safety

The cost of medical device recall goes far beyond financial losses. It risks patient safety, damages trust and exposes gaps that could have been prevented. Rolling with the punches is no longer a strategy, not when the stakes are patient lives and market credibility.

If you're integrating acquired products, sites, or suppliers, recall prevention depends on one thing: a connected quality backbone that standardizes execution while restoring visibility fast. ComplianceQuest helps quality leaders harmonize processes, reduce variation, and surface risks earlier, without forcing teams into months of manual reconciliation.

See how post-merger quality harmonization works

Frequently Asked Questions (FAQs)